Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
Hepatitis C virus (HCV) is a plus stranded RNA virus which encodes 10 different genes. The HCV NS5B gene encodes a polymerase, which is responsible for the replication of the virus and is a potential target for the development of antiviral agents. HCV has a high mutation rate and is classified into six major genotypes.
The aim of this study was to draw a representing consensus sequence of each HCV genotype, align all six consensus sequences to draw a global consensus sequence and also study the highly conserved residues.
236 HCV NS5B sequences, belonging to all six genotypes, reported from all over the world were aligned then a representing phylogenetic tree wasdrawn.
The active site residues D220, D225, D318 and D319, which bind the divalent cations, are highly conserved among all the HCV genotypes. The other catalytic pocket residues, R158, S367, R386, and T390 and R394, which interact with the triphosphate of NTPs, are also highly conserved while T390 is mutated to valine in the genotype 5. The motif B residues G283, T286, T287 and N291, which take part in sugar selection by RdRp, are also highly conserved except for T286 which is mutated to proline in the genotypes 3 and 6. The residues E18, Y191, C274, Y276 and H502, which take part in primer/template interaction, are also high conserved except for H502 which is mutated to serine in genotype 2. High variation in all the six consensus sequences was observed in a 12 amino acid beta hairpin loop, which interacts with the double stranded RNA. Nine different peptides from the highly conserved regions of HCV NS5B protein were drawn which can be used as a peptide vaccine. The HCV NS5B phylogenetic tree shows the clusters of different genotypes and their evolutionary association.
In spite of a high mutation rate in HCV, the residues which are present in the catalytic pocket, sugar selection and template/primer interaction are highly conserved. These are target sites for the development of antiviral agents or peptide vaccines. The phylogenetic analysis suggests that different HCV genotypes have been evolved from the genotype 1a.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Hussain A, Idrees M, Asif M, Ali L, Rasool M. Phylogenetic and 2D/3D Analysis of HCV 1a NS4A Gene/Protein in Pakistani Isolates. Hepat Mon. 2015;15(6):e19936. doi: https://doi.org/10.5812/hepatmon.15(6)2015.19936
Kuznetsova T, Tallo T, Brjalin V, Reshetnjak I, Salupere R, et al. Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response. Hepat Mon. 2013;13(12):e14481. doi: https://doi.org/10.5812/hepatmon.14481
Omran MH, Nabil W, Youssef SS, El-Sayed M, El Awady MK. Heterogeneity and New Epitopes of Hepatitis C Virus Genotype 4. Hepat Mon. 2013;13(8):e10521. doi: https://doi.org/10.5812/hepatmon.10521
Gededzha MP, Mphahlele MJ, Selabe SG. Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target. Hepat Mon. 2014;14(11):e23660. doi: https://doi.org/10.5812/hepatmon.23660
Salehi Moghadam F, Mohebbi SR, Hosseini SM, Damavand B, Zali MR. A New Subtype of Hepatitis C Virus Genotype 3: Analysis of Available Evidence. Hepat Mon. 2013;13(8):e13380. doi: https://doi.org/10.5812/hepatmon.13380
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 6 hours ago
Last Update: 11 hours ago
Last Update: 5 days ago
